Global Atrial Fibrillation Surgery Market 2020-2025 - Ambulatory Surgical Center Segment is Forecast to be the Fastest-Growing Segment -

DUBLIN--()--The "Atrial Fibrillation Surgery Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to's offering.

The atrial fibrillation surgery market is driven by factors such as the rising prevalence of obesity and the growing burden of heart disease across the globe. It has been indicated by the World Health Organization that obesity has been tripled in the world since 1975. In addition, heart diseases are the major cause of death across the globe and due to changing lifestyle and stress, the number of people suffering from heart diseases is increasing rapidly. Due to the growing cases of heart patients, there is a rise in the number of cases of atrial fibrillation and this is posing a high burden of the economies of various countries as the cost of treatment is higher.

Key Market Trends

Ambulatory Surgical Center Segment is expected to be the Fastest-Growing Segment over the Forecast Period

The ambulatory surgical center segment is expected to be the fastest-growing segment owing to the enhanced healthcare infrastructure, availability of skilled labor, and affordability. The rise in patients, owing to substantial growth in the geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, is expected to enhance revenue generations. Moreover, compared to conventional surgeries, the benefits of minimally invasive surgeries such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time are encouraging more patients to opt for MIS surgeries, which is expected to boost the market growth.

Furthermore, due to the rising burden of obesity, there is an increase in the number of people suffering from atrial fibrillation among such a population. Hence, it is believed that an increased prevalence of obesity is contributing to the growth of the market.

The United States Holds the Largest Share of the Market

The United States holds the largest share of the atrial fibrillation market. This is majorly attributed to a large number of people suffering from this disease in the country and the presence of key players. As per the statistics provide by the CDC (Centre for Disease Control and Prevention), there are around 2.7-6.1 million people in the United States have AFib and with the rising geriatric population, it is expected that this number will grow in the future. High blood pressure which is one of the leading causes of atrial fibrillation accounts for around 14% to 22% of all AFib cases in the country. With the presence of key players in the country and availability of favorable insurance policies, people across the country are able to get the surgery done at low costs which are augmenting the growth of the market studied in the United States.

Competitive Landscape

The market for atrial fibrillation is moderately competitive and consists of local as well as global companies. Most of the developed countries are being dominated by international players whereas, developing countries are witnessing the penetration of new entrants in the market. With the technological advancements and the focus of developing economies on improving the healthcare system, it is expected that more companies will enter the market and hold a substantial share in the future.

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Prevalence of Obesity

4.2.2 Increased Burden of Heart Diseases

4.2.3 Rising Number of Programs to Enhance Public Awareness

4.3 Market Restraints

4.3.1 High Cost of Procedure

4.3.2 Regulatory Issues Associated with the Devices

4.4 Porter's Five Force Analysis


5.1 By Product

5.1.1 Catheter Ablation

5.1.2 Surgical Ablation

5.2 By End-User

5.2.1 Hospitals

5.2.2 Ambulatory Surgical Centers

5.2.3 Others

5.3 Geography


6.1 Company Profiles

6.1.1 Boston Scientific Corporation

6.1.2 Medtronic Plc

6.1.3 Biotronik

6.1.4 AtriCure, Inc.

6.1.5 Cardiofocus, Inc.

6.1.6 Abbott Laboratories

6.1.7 Advansta, Inc.


For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900